Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.
- Bloemberg GV University of Zurich, Zurich, Switzerland.
- Keller PM
- Stucki D
- Stuckia D
- Trauner A
- Borrell S
- Latshang T
- Coscolla M
- Rothe T
- Hömke R
- Ritter C
- Feldmann J
- Schulthess B
- Gagneux S
- Böttger EC
- 2015-11-13
Published in:
- The New England journal of medicine. - 2015
Antitubercular Agents
Diarylquinolines
Drug Resistance, Bacterial
Drug Therapy, Combination
Humans
Male
Mutation
Mycobacterium tuberculosis
Nitroimidazoles
Oxazoles
Tuberculosis, Multidrug-Resistant
English
Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1056/NEJMc1505196
- PMID 26559594
- Persistent URL
- https://sonar.ch/global/documents/35702
Statistics
Document views: 57
File downloads:
- Full-text: 0